Evidence map›Paper›PMID 35477870›Full record

ArticleBMJ open2022

Supervised physical activity in patients with symptomatic peripheral arterial disease: protocol for a randomized clinical trial (ARTPERfit Study).

Maria Teresa Alzamora, Rosa Forés, Noemi Serra, Esau Martinez, Guillem Pera, Gemma Seda, Joan Lopez Palencia, Manuel Gomis, Antonio Heras Tébar, Marta Valverde and 2 more

Registry-linked trialOpen access · goldAbstract readClinical Trial Protocol
In one paragraph

Article in BMJ open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04578990 (Supervised Physical Activity in Subjects With Symptomatic Peripheral Arterial Disease. ARTPERfit Randomized Clinical Trial.), which is not on this map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04578990 naunknown statusnot on this map

Supervised Physical Activity in Subjects With Symptomatic Peripheral Arterial Disease. ARTPERfit Randomized Clinical Trial.

TypeinterventionalSponsorFundacio d'Investigacio en Atencio Primaria Jordi Gol i GurinaRan2021 to 2023Enrolled124ConditionsPeripheral Arterial Disease, ArteriosclerosisArmsWalking intervention, Strength intervention, Concurrent intervention
3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 2 citations in OpenAlex.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Maria Teresa AlzamoraFamily Medicine Riu Nord-Riu Sud, Institut Català de la Salut, Santa Coloma de Gramenet, Spain maiteal2007@gmail.com.ORCID 0000-0002-0094-6547
Rosa ForésUSR Metropolitana Nord, IDIAP Jordi Gol, Barcelona, Spain.
Noemi SerraUniversitat Pompeu Fabra Escola Superior Politècnica del TecnoCampus, Mataro, Spain.
Esau MartinezVascular Surgery, Hospital de Mataró, Mataro, Spain.
Guillem PeraUSR Metropolitana Nord. Mataró, IDIAP Jordi Gol, Barcelona, Spain.
Gemma SedaInstitut Catala De La Salut, Barcelona, Spain.
Joan Lopez PalenciaVascular Surgery, Hospital de Mataró, Mataro, Spain.
Manuel GomisUniversitat Pompeu Fabra Escola Superior Politècnica del TecnoCampus, Mataro, Spain.
Antonio Heras TébarUSR Metropolitana Nord, IDIAP Jordi Gol, Barcelona, Spain.ORCID 0000-0001-8132-6712
Marta ValverdeHospital Nostra Senyora de Meritxell, Escaldes-Engordany, Andorra.
Manuel Vicente GarnachoUniversitat Pompeu Fabra Escola Superior de Ciències de la Salut TecnoCampus, Mataro, Spain.
Pere ToránUnitat de Suport a la Recerca Metropolitana Nord, Institut Català de la Salut, Barcelona, Spain.
Institut Universitari d'Investigació en Atenció Primària Jordi Gol · ESUniversitat Pompeu Fabra · ESHospital de Mataró · ESInstitut Català de la Salut · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionPeripheral arterial disease (PAD) is a marker of cardiovascular morbidity, causing disability, loss of mobility and poor quality of life, manifesting clinically in the form of intermittent claudication (IC). Physical exercise increases the distance walked and improves quality of life. The aim of our study will be increased walking distance prolonging the time of onset of pain in patients with symptomatic PAD (IC). METHODS AND ANALYSIS: This study will be performed in Mataró Hospital's vascular surgery service and School of Health Sciences, TecnoCampus. This population comes from 15 primary healthcare centres ofNorth Barcelona, Spain (450 000 inhabitants).This study will be a four-group parallel, longitudinal, randomised controlled trial, blind to analysis.The main primary outcome of this study will be the improvement in pain-free walking distance. Others primary objectives are and improvement in functional status, quality of life and Ankle-Brachial Index (ABI). Secondary outcomes will be the analysis of cardiorespiratory fitness, evaluation of muscle fitness, determine the maintenance of primary objectives at 6 and 12 months.We will be included 124 patients (31 per group). The changes of the outcome (Barthel, SF-12, VascQOL-6, ABI) of the three intervention groups vs the control group at 3, 6 and 12 months will be compared, both continuously (linear regression) and categorically (logistic regression). A person who has not performed at least 75% of the training will be considered to have not completed the intervention. ETHICS AND DISSEMINATION: The study will be conducted according to the Declaration of Helsinki . It was approved by the Ethics Committee of the Research Institute Primary Health IDIAP Jordi Gol (20/035 P),Barcelona 6 October 2020. Informed consent will be obtained from all patients before the start of the study. We will disseminate results through academic papers and conference presentations. TRIAL REGISTRATION NUMBER: NCT04578990.

Indexed as

ExercisePeripheral Arterial DiseaseAnkle Brachial IndexHumansQuality of LifeRandomized Controlled Trials as TopicWalkingClinical trialsMedical education & trainingPrimary careProtocols & guidelinesSports medicineVascular medicine

Identifiers

PMID35477870
PMCPMC9047770
OpenAlexW4225095644

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.